Niedrige Seroprävalenz von Syphilis und HIV bei Flüchtlingen in Deutschland im Jahr 2015

Abstract

Background | Currently only estimates exist of seroprevalence of syphilis and human immunodeficiency virus (HIV) in refugees arriving in Germany during the current refugee crisis. Objectives | To assess the prevalence of syphilis and human immunodeficiency virus (HIV) in refugees arriving in northern Germany in 2015. Materials and methods | In a cross-sectional study in 790 patients from all age groups tests for serological markers of treponema pallidum and in 789 patients for human immunodeficiency virus (HIV) were performed in August 2015 in reception centers in northern Germany. Results | The overall prevalence of treponema pallidum antibodies was 0.13 % (1/790; [95 % CI: 0 - 0.4]). HIV antibodies were positive in two refugees from sub-Saharan Africa (2/789; 0.25 %, [95 % CI: 0 - 0.6]). Conclusions | This study showed a low prevalence of treponema pallidum antibodies and human immunodeficiency virus infection (HIV) in a German refugee cohort, not significantly different from German controls.

Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening

“…On the other hand, Syrian migrants have been shown to have low HBsAg prevalence [ 19 , 27 ], but Syrians represented only a clear minority in our study population. The observed HIV prevalence of 0.3% was lower or comparable to other studies among asylum seekers to Europe during the migrant crisis in 2015–2016 [ 16 , 20 , 25 – 28 , 31 ].…”

“…We described the public health response to the large influx of asylum seekers to Finland during 2015–2016 by evaluating the implementation and timing of infectious disease screenings using healthcare procurement data. As a contrast to other studies performed in healthcare settings [ 19 , 20 ] or in selected regions of destination countries [ 16 – 20 , 25 – 28 ], our study included an national asylum seeker population, which reinforces the external validity of our results. Due to the service providers’ financial interests, the healthcare procurement data are likely to be accurate, available and internally valid.…”

“…While there are several reports on the screening yields of infectious diseases among newly-arrived asylum seekers to Europe [ 16 – 20 ], only a few [ 21 , 22 ] have focused on describing the implementation of the public health response. As dimensions of the public health response, we aimed to evaluate the implementation of the national guidelines, including screening coverage, timing, assessment of vulnerability and screening yields, during the large influx of asylum seekers to Finland in 2015–2016.…”

Aktuelle Seroprävalenz, Impfstatus und prädiktiver Wert der Leberenzyme für Hepatitis B bei Flüchtlingen in Deutschland

“…Nach Aufklä-rung in der jeweiligen Landessprache wurde jedem Flüchtling, der sich aufgrund von akuten Beschwerden in ärzt-liche Behandlung begab, im Rahmen einer ersten Routineversorgung eine Blutentnahme zur Testung auf sexuell übertragbare Erkrankungen wie HIV und Syphilis [14] und impfpräventable Erkrankungen wie Masern, Mumps, Rö-teln, Varizellen inklusive einem Test auf eine Hepatitis-B-Virusinfektion angeboten. Dies erfolgte, um gemäß Leitlinie der deutschen Gesellschaft für Verdauungsund Stoffwechselkrankheiten (DGVS) [15] (5,(9)(10)(11)(12)(13)4) Männlich 215 (11,(9)(10)(11)(12)(13)(14)(15)(16)9) Männlich 608 Bei N = 239 Flüchtlingen lagen Daten zu anti-HBs-Antikörperkonzentra-tionen vor. 62,4 % (n = 161) der Flüchtlin-ge besaßen keine Immunität gegen Hepatitis B (anti-HBs und anti-HBc negativ).…”

Gesundheitsversorgung von Asylsuchenden in Deutschland nach Asylbewerberleistungsgesetz: Wahrnehmung und Präferenzen der Bevölkerung

“…Doch auch objektiv betrachtet wurde die Studienpopula tion als eher schlecht informiert eingestuft. Exemplarisch ist die Gefahr durch Infektionserkrankungen, die von einem Drittel der Befragten befürchtet wurde, in der Realität als eher gering einzuschätzen [15].…”